IRONWOOD PHARMACEUTICALS INC·4

Jun 5, 4:39 PM ET

Owens Edward P 4

4 · IRONWOOD PHARMACEUTICALS INC · Filed Jun 5, 2020

Insider Transaction Report

Form 4
Period: 2020-06-03
Transactions
  • Award

    Class A Common Stock

    2020-06-03+21,720203,954 total
Holdings
  • Class A Common Stock

    (indirect: By Foundation)
    40,000
Footnotes (2)
  • [F1]The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
  • [F2]The reporting person and certain members of his family are trustees of the foundation, the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the securities.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_920315

    POA DOCUMENT